Literature DB >> 11015613

Large-scale analysis of gene expression changes during acute and chronic exposure to [Delta]9-THC in rats.

J T Kittler1, E V Grigorenko, C Clayton, S Y Zhuang, S C Bundey, M M Trower, D Wallace, R Hampson, S Deadwyler.   

Abstract

Large-scale cDNA microarrays were employed to assess transient changes in gene expression levels following acute and chronic exposure to cannabinoids in rats. A total of 24,456 cDNA clones were randomly selected from a rat brain cDNA library, amplified by PCR, and arrayed at high density to investigate differential gene expression profiles following acute (24 h), intermediate (7 days), and chronic (21 days) exposure to Delta(9)-tetrahydrocannabinol (Delta(9)-THC), the psychoactive ingredient of marijuana. Hippocampal mRNA probes labeled with (33)P obtained from both vehicle and Delta(9)-THC-treated animals were hybridized with identical cDNA microarrays. Results revealed a total of 49 different genes altered by Delta(9)-THC exposure; of these, 28 were identified, 10 had homologies to expressed sequence tags (ESTs), and 11 had no homology to known sequences in the GenBank database. Chronic or acute cannabinoid receptor activation altered expression of several genes (i.e., prostaglandin D synthase, calmodulin) involved in biochemical cascades of cannabinoid synthesis or cannabinoid effector systems. Other genes [i.e., neural cell adhesion molecule (NCAM), myelin basic protein], whose relation to cannabinoid system function was not immediately obvious, were also significantly altered. Verification of the changes obtained with the large-scale screen was determined by RNA dot blots in different groups of animals treated the same as those in the large-scale screen. Results are discussed in terms of the different types of genes affected at different times during chronic Delta(9)-THC exposure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11015613     DOI: 10.1152/physiolgenomics.2000.3.3.175

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  18 in total

Review 1.  Microarray technology and its application on nicotine research.

Authors:  Ming D Li; Ozien Konu; Justin K Kane; Kevin G Becker
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

Review 2.  Molecular model of cannabis sensitivity in developing neuronal circuits.

Authors:  Erik Keimpema; Ken Mackie; Tibor Harkany
Journal:  Trends Pharmacol Sci       Date:  2011-07-13       Impact factor: 14.819

3.  Associations between adolescent cannabis use and brain structure in psychosis.

Authors:  Hila Abush; Subroto Ghose; Erin A Van Enkevort; Brett A Clementz; Godfrey D Pearlson; John A Sweeney; Matcheri S Keshavan; Carol A Tamminga; Elena I Ivleva
Journal:  Psychiatry Res Neuroimaging       Date:  2018-03-28       Impact factor: 2.376

4.  Δ9-Tetrahydrocannabinol changes the brain lipidome and transcriptome differentially in the adolescent and the adult.

Authors:  Emma Leishman; Michelle Murphy; Ken Mackie; Heather B Bradshaw
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-02-08       Impact factor: 4.698

Review 5.  The endocannabinoid system as a target for the treatment of neurodegenerative disease.

Authors:  Emma L Scotter; Mary E Abood; Michelle Glass
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

6.  Systemic Blockade of the CB1 Receptor Augments Hippocampal Gene Expression Involved in Synaptic Plasticity but Perturbs Hippocampus-Dependent Learning Task.

Authors:  Kofi-Kermit A Horton; Anushka V Goonawardena; John Sesay; Allyn C Howlett; Robert E Hampson
Journal:  Cannabis Cannabinoid Res       Date:  2019-03-13

7.  Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway.

Authors:  Giuseppe Tortoriello; Claudia V Morris; Alan Alpar; Janos Fuzik; Sally L Shirran; Daniela Calvigioni; Erik Keimpema; Catherine H Botting; Kirstin Reinecke; Thomas Herdegen; Michael Courtney; Yasmin L Hurd; Tibor Harkany
Journal:  EMBO J       Date:  2014-01-27       Impact factor: 11.598

8.  Transcriptomic and proteomic analyses of mouse cerebellum reveals alterations in RasGRF1 expression following in vivo chronic treatment with delta 9-tetrahydrocannabinol.

Authors:  Graziano Colombo; Francesco Rusconi; Tiziana Rubino; Angela Cattaneo; Enzo Martegani; Daniela Parolaro; Angela Bachi; Renata Zippel
Journal:  J Mol Neurosci       Date:  2008-06-27       Impact factor: 3.444

9.  Increases in expression of 14-3-3 eta and 14-3-3 zeta transcripts during neuroprotection induced by delta9-tetrahydrocannabinol in AF5 cells.

Authors:  Jia Chen; Chun-Ting Lee; Stacie L Errico; Kevin G Becker; William J Freed
Journal:  J Neurosci Res       Date:  2007-06       Impact factor: 4.164

10.  Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin.

Authors:  Dawn N Albertson; Barb Pruetz; Carl J Schmidt; Donald M Kuhn; Gregory Kapatos; Michael J Bannon
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.